CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Use of a High-Throughput Genotyping Platform (OncoMap) for RAS Mutational Analysis to Predict Cetuximab Efficacy in Patients with Metastatic Colorectal Cancer

Dalyong Kim, Yong Sang Hong, Jeong Eun Kim, Kyu-pyo Kim, Jae-Lyun Lee, Sung-Min Chun, Jihun Kim, Se Jin Jang, Tae Won Kim

Cancer Research and Treatment. 2017;49(1):37-43. Published online 2016 April 27 DOI: https://doi.org/10.4143/crt.2016.069

Use of a High-Throughput Genotyping Platform (OncoMap) for <i>RAS</i> Mutational Analysis to Predict Cetuximab Efficacy in Patients with Metastatic Colorectal Cancer

Dalyong Kim, Yong Sang Hong, Jeong Eun Kim, Kyu-pyo Kim, Jae-Lyun Lee, Sung-Min Chun, Jihun Kim, Se Jin Jang, Tae Won Kim

Cancer Research and Treatment. 2017;49(1):37-43

Link1

Link2 Link3

156P High-throughput genotyping platform (OncoMap), a precise tool for predicting cetuximab efficacy in patients with metastatic colorectal cancer

D. Kim, Y.S. Hong, J.E. Kim, K.-P. Kim, J.-L. Lee, J. Kim, S.J. Jang, T.W. Kim

Annals of Oncology. 2015;26:ix42

Link1 Link2

Quality of Life Analysis in Patients With RAS Wild-Type Metastatic Colorectal Cancer Treated With First-Line Cetuximab Plus Chemotherapy

Kensei Yamaguchi, Masahiko Ando, Akira Ooki, Frank Beier, Silke Guenther, Philipp von Hohnhorst, Eric Van Cutsem

Clinical Colorectal Cancer. 2017;16(2):e29-e37

Link1 Link2

P-010 Next generation sequencing mutational analysis of primary and metastatic colorectal cancer samples in relationship to efficacy of cetuximab-based therapy

R. Nemecek, J. Berkovcova, O. Slaby, M. Svoboda

Annals of Oncology. 2016;27:ii3

Link1 Link2 Link3

Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS

Jing Yang, Xinli Guo, Manni Wang, Xuelei Ma, Xiaoyang Ye, Panpan Lin

Scientific Reports. 2017;7(1):

Link1

Link2 Link3

Cost-Effectiveness Analysis Of Cetuximab And Panitumumab For First Line Treatment Of Metastatic Colorectal Cancer (Mcrc) In Wt Ras Patients In Spain

J Suarez

Value in Health. 2015;18(7):A460

Link1 Link2

Phase II Study of Cetuximab Rechallenge in Patients with RAS Wild-Type metastatic Colorectal Cancer: E-Rechallenge Trial

Masato Nakamura

Annals of Oncology. 2019;30:vi116

Link1 Link2 Link3

Link4

Association between HER2 amplification and cetuximab efficacy in patients with RAS wild-type metastatic colorectal cancer

J. Jeong, J. Kim, Y.S. Hong, D. Kim, J.E. Kim, S.Y. Kim, K.-P. Kim, T.W. Kim

Annals of Oncology. 2016;27:vi172

Link1 Link2 Link3

Germline Polymorphisms in Genes Involved in the Antioxidant System Predict the Efficacy of Cetuximab in Metastatic Colorectal Cancer Patients Enrolled in FIRE-3 Trial

Hiroyuki Arai, Joshua Millstein, Yan Yang, Sebastian Stintzing, Jingyuan Wang, Francesca Battaglin, Natsuko Kawanishi, Priya Jayachandran, Shivani Soni, Wu Zhang, Volker Heinemann, Heinz-Josef Lenz

Clinical Colorectal Cancer. 2022;21(3):259-266

Link1 Link2

Pilot Clinical Trial on the Efficacy of Prophylactic Use of Vitamin K1–Based Cream (Vigorskin) to Prevent Cetuximab-Induced Skin Rash in Patients With Metastatic Colorectal Cancer

Francesco Pinta, Agostino Ponzetti, Rosella Spadi, Laura Fanchini, Marcello Zanini, Caterina Mecca, Cristina Sonetto, Libero Ciuffreda, Patrizia Racca

Clinical Colorectal Cancer. 2014;13(1):62-67

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.